TMP Stock News Tompkinstrustco (TMP) 44.04 08/02/2014 04:27:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tompkinstrustco (TMP) 44.04 $TMP

Fulmer Retiring as President of Tompkins Bank of Castile
Business Wire - Wed Jul 30, 3:45PM CDT
After 26 years as president and CEO of Tompkins Bank of Castile, James W. Fulmer is retiring from those roles at the end of this year, but will remain as chairman of the bank's Board of Directors, said Stephen S. Romaine, president and CEO of Tompkins Financial Corporation, the bank's parent company.

Tompkins Financial Corporation Reports Record Second Quarter Earnings
Business Wire - Fri Jul 25, 8:00AM CDT
Tompkins Financial Corporation (NYSEMKT:TMP)

Tompkins Financial Corporation Declares Cash Dividend
Business Wire - Fri Jul 25, 8:00AM CDT
Tompkins Financial Corporation (NYSEMKT:TMP)

Tompkins Financial Corporation Announces Approval of Stock Repurchase Program
Business Wire - Fri Jul 25, 8:00AM CDT
Tompkins Financial Corporation (NYSEMKT:TMP)

Tompkins Financial names Susan Valenti as EVP of Corporate Marketing
M2 - Tue Jun 17, 3:05AM CDT
Tompkins Financial Corporation (NYSE MKT:TMP) revealed today (Tuesday) that Susan Valenti has been promoted as executive vice president (EVP) of Corporate Marketing.

Tompkins Financial Corp. Promotes Susan Valenti to Executive Vice President
Business Wire - Mon Jun 16, 1:53PM CDT
Tompkins Financial Corporation (TMP - NYSE MKT LLC)

Tompkins Financial Corp. Promotes Rosemary Hyland to Executive Vice President
Business Wire - Mon Jun 16, 1:42PM CDT
Tompkins Financial Corporation (TMP - NYSE MKT LLC)

Tompkins Financial Corporation Names Stephen Angelis as New President of Tompkins Financial Advisors
Business Wire - Thu Feb 06, 8:41AM CST
Tompkins Financial Corporation (TMP - NYSE MKT LLC) - Tompkins Financial today announced that Stephen M. Angelis has been named President of Tompkins Financial Advisors, the wealth management division of the Company, with offices in Ithaca, Pittsford and White Plains, New York, and Wyomissing and Blue Bell, Pennsylvania. In addition, he will serve as a member of the Leadership Team of Tompkins Financial Corporation. Mr. Angelis will join the Company on February 18, 2014.

Tompkins Financial announces dividend of USD0.40 per share
M2 - Mon Jan 27, 7:56AM CST
The board of directors for US-based financial services company Tompkins Financial Corporation (NYSE MKT:TMP) authorised the payment of a regular common stock cash dividend of USD0.40 per share, the company declared on Friday.

Tompkins Financial Corporation Reports Record Quarterly and Annual Earnings
Business Wire - Fri Jan 24, 8:00AM CST
Tompkins Financial Corporation (TMP-NYSE MKT LLC)

Tompkins Financial Corporation Promotes Scott Gruber to CEO of VIST Bank
Business Wire - Tue Jan 07, 8:27AM CST
Tompkins Financial Corporation (TMP - NYSE MKT LLC) - Tompkins Financial today announced that Scott L. Gruber has been promoted to Chief Executive Officer of VIST Bank, a Tompkins community bank headquartered in Wyomissing, PA. He succeeds Robert D. Davis, who retired as CEO on December 31, 2013. Gruber, of Ontelaunee Township, Berks County, joined Tompkins on April 30, 2013 as president and chief operating officer of VIST Bank. He retains the title of president.

Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 14, 8:01AM CDT
Here are 5 stocks added to the Zacks #5 Rank ("strong sell" List for Wednesday

Tompkins Financial names Dr Thomas Rochon as board chairman succeeding James J Byrnes in 2014
M2 - Fri Aug 02, 4:05AM CDT
A financial services company, Tompkins Financial Corporation's (NYSE MKT:TMP) board of directors concluded a succession planning process and on Thursday named Dr Thomas R Rochon as successor to the present chairman James J Byrnes, whose term expires in May 2014.

Tompkins Financial Corporation identifies Dr. Thomas Rochon as successor to Board Chairman in 2014
Business Wire - Thu Aug 01, 11:00AM CDT
Tompkins Financial Corporation (TMP - NYSE MKT LLC) & Ithaca College - The Tompkins Financial Corporation Board of Directors concluded a succession planning process for Chairman James J. Byrnes, whose term will expire in May 2014, by naming current director, Dr. Thomas R. Rochon as his successor. Mr. Byrnes has served as Chairman of the Board of the Company since its formation in 1995. Dr. Rochon has served as a Director of the Company since 2009. He is currently President of Ithaca College, a position he has held since July 2008 and which he will continue to hold while serving as Chairman.

Tompkins Financial Corporation Reports Increase in Second Quarter Earnings
Business Wire - Fri Jul 19, 8:00AM CDT
Tompkins Financial Corporation (TMP-NYSE MKT LLC)

TMP Expected To Be Down Before Next Earnings Releases
M2 - Wed Jul 17, 4:13AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and July earnings reports. Tompkins Financial Corp (AMEX:TMP) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Do

Tompkins Financial Corporation Reports Strong First Quarter Operating Results
Business Wire - Fri Apr 26, 8:00AM CDT
Tompkins Financial Corporation (TMP-NYSE MKT LLC)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading